Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains

Journal of Neuroscience

Volumn 25, Issue 44, 2005, Pages 10198-10206

  Eisensamer, Brigitte ^a,b   Uhr, Manfred ^a   Meyr, Sabrina ^a   Gimpl, Gerald ^c   Deiml, Tobias ^b   Rammes, Gerhard ^a,e   Lambert, Jeremy J ^d   Zieglgänsberger, Walter ^a   Holsboer, Florian ^a   Rupprecht, Rainer ^a,b,f  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

5 HT3 receptor; Antidepressants; Antipsychotics; Ligand gated ion channel; Lipid rafts; Receptor internalization

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; DESIPRAMINE; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; ION CHANNEL; MIRTAZAPINE; MOCLOBEMIDE; NEUROLEPTIC AGENT; PROTRIPTYLINE; REBOXETINE; RISPERIDONE;

ANIMAL CELL; ARTICLE; CHANNEL GATING; COMPETITIVE INHIBITION; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; INTERNALIZATION; ION TRANSPORT; NERVE EXCITABILITY; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CELL LINE; HUMANS; MEMBRANE MICRODOMAINS; PROTEIN BINDING; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 27744584045     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2460-05.2005     Document Type: Article

References (74)

1. Abrami L, Liu S, Cosson P, Leppla SH, van der Goot FG (2003) Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J Cell Biol 160:321-328.
2. Anderson RG (1998) The caveolae membrane system. Annu Rev Biochem 67:199-225.
3. A receptors. Int Rev Neurobiol 39:53-76.
4. Becher A, White JH, McIlhinney RAJ (2001) The γ-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J Neurochem 79:787-795.
5. Besshoh S, Bawa D, Teves L, Wallace MC, Gurd JW (2005) Increased phosphorylation and redistribution of NMDA receptors between synaptic lipid rafts and post-synaptic densities following transient global ischemia in the rat brain. J Neurochem 93:186-194.
6. Bickel MH, Steele JW (1974) Binding of basic and acidic drugs to rat tissue subcellular fractions. Chem Biol Interact 25:55-86.
7. Blakely RD (2001) Physiological genomics of antidepressant targets: keeping the periphery in mind. J Neurosci 21:8319-8323.
8. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917.
9. Bolo NR, Hodé Y, Nédélec JF, Lainé E, Wagner G, Macher JP (2000) Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 23:428-438.
10. 3 receptors: the role of oligomerization and chaperone proteins. Mol Cell Neurosci 21:38-50.
11. 3 receptor by nicotine, cocaine, and fluoxetine investigated by rapid chemical kinetic techniques. Biochem 40:8419-8429.
12. Brown DA, London E (1998) Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136.
13. Brown DA, Rose JK (1992) Sortingof GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533-544.
14. Bruses JL, Chauvet N, Rutishauser U (2001) Membrane lipid rafts are necessary for the maintenance of the α7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J Neurosci 21:504-512.
15. Burgi S, Baltensperger K, Honegger UE (2003) Antidepressant-induced switch of β1-adrenoceptor trafficking as a mechanism for drug action. J Biol Chem 278:1044-1052.
16. A) receptor polypeptides from the neuronal surface. J Protein Chem 13:438.
17. Connolly CN, Uren JM, Thomas P, Gorrie GH, Gibson A, Smart TG, Moss SJ (1999) Subcellular localization and endocytosis of homomeric γ2 subunit splice variants of γ-aminobutyric acid type A receptors. Mol Cell Neurosci 13:259-271.
18. A receptor and Na +, K + ATPase in discrete microdomain clusters in rat cerebellar granule cells. Neurochem Int 46:489-499.
19. 3B subunit is a major determinant of serotonin-receptor function. Nature 397:359-363.
20. Di Francesco C, Bickel MH (1977) Membrane lipids as intracellular binders of chloropromazine and related drugs. Chem Biol Interact 16:335-346.
21. Donati RJ, Thukral C, Rasenick MM (2001) Chronic treatment of C6 glioma cells with antidepressant drugs results in a redistribution of Gsα. Mol Pharmacol 59:1426-1432.
22. Edidin M (2003) The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol Struct 32:257-283.
23. 3) receptor. Mol Psychiatry 8:994-1007.
24. 3 receptor-mediated current by the selective serotonin uptake inhibitor, fluoxetine. Neurosci Lett 173:210-212.
25. Fra AM, Williamson E, Simons K, Parton RG (1995) De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc Natl Acad Sci USA 92:8655-8659.
26. Gimpl G, Fahrenholz F (2000) Human oxytocin receptors in cholesterolrich vs. cholesterol-poor microdomains of the plasma membrane. FEBS Lett 267:2483-2497.
27. Henry ME, Moore C, Kaufmann M, Michelson D, Schmidt M, Stoddard E Vuckevic AJ, Berreira P, Cohen BM, Renshaw PF (2000) Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution: a fluorine MRS study. Am J Psychiatry 157:1506-1508.
28. Hering H, Lin CC, Sheng M (2003) Lipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stability. J Neurosci 23:3262-3271.
29. 3 receptor. Biochem Biophys Res Commun 225:957-960.
30. Hooper NM (1999) Detergent-insoluble glycoshingolipid/cholesterol-rich membrane domains, lipid rafts and caveolae. Mol Membr Biol 16:145-156.
31. 3 receptor trafficking in live cells. J Biol Chem 279:53346-53352.
32. Kinon BJ, Lieberman IA (1996) Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124:2-34.
33. Korpi ER, Wong G, Luddens H (1995) Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine. Naunyn Schmiedebergs Arch Pharmacol 352:365-373.
34. Koshikawa N, Durcan MJ, Weaver K, Lawrence K, Campbell IC (1987) Subcellular distribution of β-adrenoceptors in brain following administration of antidepressant drugs. Neuropharmacology 26:1343-1349.
35. Kurzchalia TV, Parton RG (1999) Membrane microdomains and caveolae. Curr Opin Cell Biol 11:424-431.
36. 3 receptor cDNA and its splice variants from Guinea Pig. Mol Pharmacol 53:202-212.
37. Ledesma MD, Simons K, Dotti CG (1998) Neuronal polarity: essential role of protein-lipid complexes in axonal sorting. Proc Natl Acad Sci USA 95:3966-3971.
38. Luria A, Vegelyte-Avery V, Stith B, Tsvetkova NM, Wolkers WF, Tablin F, Nuccituelli R (2002) Detergent-free domain isolated from Xenopus egg plasma membrane with properties similar to those of detergent-resistant membranes. Biochemistry 41:13189-13197.
39. Malatynska E, Crites GI, Harrawood D, Goldenberg D, Matheson GK (2000) Antidepressant effects on GABA-stimulated 36 Cl(-) influx in rat cerebral cortex are altered after treatment with GABA(A) receptor antisense oligodeoxynucleotides. Brain Res 869:78-84.
40. v channels to lipid rafts. Trends Pharmacol Sci 25:16-21.
41. Marx CE, Van Doren MJ, Duncan GE, Lieberman IA, Morrow AL (2003) Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents. Neuropsychopharmacology 28:1-13.
42. Mineo C, Gill GN, Anderson RGW (1999) Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 274:30636-30643.
43. Miranda JD, Barnes EMJR (1997) Repression of γ-aminobutyric acid type A receptor α1 polypeptide biosynthesis requires chronic agonist exposure. J Biol Chem 272:16288-16294.
44. A receptors. J Neurosci 19:2474-2488.
45. Munro S (2003) Lipid rafts: elusive or illusive? Cell 115:377-388.
46. Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:263-270.
47. Murata M, Peranen J, Schreiner R, Wieland F, Kurzchalia TV, Simons K (1995) VIP21/caveolin is a cholesterol-binding protein. Proc Natl Acad Sci USA 92:10339-10343.
48. Okamoto T, Schlegel A, Scherer PE, Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422.
49. Pacher P, Kohegyi E, Kecskemeti V, Frust S (2001) Current trends in the development of new antidepressants. Curr Med Chem 8:89-100.
50. Pike LJ (2003) Lipid rafts: bringing order to chaos. J Lipid Res 44:655-667.
51. Procyshyn RM, Kennedy NB, Marriage S, Wasan KM (2001) Plasma protein and lipoprotein distribution of clozapine. Am J Psychiatry 158:949-951.
52. Rammes G, Eisensamer B, Ferrari U, Shapa M, Gimpl G, Gilling K, Parsons C, Riering K, Hapfelmeier G, Bondy B, Zieglgansberger W, Holsboer F, Rupprecht R (2004) Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol Psychiatry 9:846-858.
53. 1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F] MPPF in the nucleus raphe dorsalis of rat. J Neurosci 24:5420-5426.
54. A receptor activity through a novel modulatory site. J Pharmacol Exp Ther 304:978-984.
55. Romeo E, Ströhle A, Spalletta G, di Michele F, Hermann B, Holsboer F, Pasini A, Rupprecht R (1998) Effects of antidepressant treatment on neuroactive steroids in major depression. Am J Psychiatry 155:910-913.
56. Romer J, Bickel MH (1979) Interactions of chloropromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. Biochem Pharmacol 28:799-805.
57. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG (1992) Caveolin, a protein component of caveolae membrane coats. Cell 68:673-682.
58. Sargiacomo M, Sudol M, Tang Z, Lisanti MP (1993) Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins from a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.
59. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P (1995) Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269:1435-1439.
60. Smart EJ, Ying Y-S, Mineo C, Anderson RGW (1995) A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92:10104-10108.
61. Smart EJ, Ying Y-S, Donzell WC, Anderson RGW (1996) A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J Biol Chem 271:29427-29435.
62. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP (1996) Co-purification and direct interaction of ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271:9690-9697.
63. Stan RV, Roberts WG, Predescu D, Ihida D, Saucan L, Ghitescu L, Palade GE (1997) Immunoisolation and partial characterization of endothelial plasmalemmal vesicles (caveolae). Mol Biol Cell 8:595-605.
64. Suzuki T, Ito J, Takagi H, Saitoh F, Nawa H, Shimizu H (2001) Biochemical evidence for localization of AMPA-type glutamate receptor subunits in the dendritic raft. Mol Brain Res 89:20-28.
65. A receptors on clathrin-coated vesicles during chronic benzodiazepine administration in vivo. J Pharmacol Exp Ther 283:384-391.
66. Tillman T, Cascio M (2003) Effects of membrane lipids on ion channel structure and function. Cell Biochem Biophys 38:161-190.
67. sα from plasma membrane. J Neurochem 73:1114-1120.
68. Tsui-Pierchala BA, Encinas M, Milbrandt J, Johnson Jr EM (2002) Lipid rafts in neuronal signaling and function. Trends Neurosci 25:412-417.
69. Uhr M, Steekler T, Yassouridis A, Holsboer F (2000) Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to Mdr1a P-glycoprotein gene disruption. Neuropsychopharmacology 22:380-387.
70. Uzunov DP, Cooper TB, Costa E, Guidotti A (1996) Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA 93:12599-12604.
71. Waugh MG, Lawson D, Hsuan JJ (1999) Epidermal growth factor receptor activation is localized within low-buoyant density, non-caveolar membrane domains. Biochem J 337:591-597.
72. Weigmann H, Härtter S, Bagli M, Hiemke C (2000) Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine. Eur Neuropsychopharmacol 10:401-405.
73. Wetzel CHR, Hermann B, Behl C, Pestel E, Rammes G, Ziegelgansberger W, Holsboer F, Rupprecht R (1998) Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor. Mol Endocrinol 12:1441-1451.
74. Willins DL, Berry SA, Alsayegh L, Backstrom JR, Sanders-Bush E, Friedman L, Roth BL (1999) Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptmaine-2A receptors in vitro and in vivo. Neuroscience 91:599-606.